WallStreetZenWallStreetZen

NASDAQ: CPIX
Cumberland Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Cumberland Pharmaceuticals earnings were -$10.9M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CPIX earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$1.5M, up 42.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CPIX reported annual earnings of -$6.3M, with 12.7% growth.

CPIX earnings history

Current Revenue
$36.8M
Current Earnings
-$10.9M
Current Profit Margin
-29.6%

CPIX Return on Equity

Current Company
-40.2%
Current Industry
12.9%
Current Market
35.6%
CPIX's Return on Equity (-40.2%)... subscribe to Premium to read more.
High Return on Equity Performance

CPIX Return on Assets

Current Company
-13.6%
Current Industry
5.8%
CPIX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CPIX announces earnings.

CPIX Return on Capital Employed

Current Company
-22.45%
Current Industry
11.8%
CPIX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CPIX vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CPIX-$3.92M-$10.87MN/A-$0.77
CYTH-$24.79M-$24.80MN/A-$0.90
GELS-$1.91M-$2.30MN/A-$0.29
TXMD-$2.42M-$3.32MN/A-$0.26
FLGC-$18.78M-$19.22MN/A-$1.69
View Top Pharmaceutical Stocks

Cumberland Pharmaceuticals Earnings Reports & History FAQ

What were Cumberland Pharmaceuticals's earnings last quarter?

On CPIX's earnings call on Invalid Date, Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 2024 earnings per share (EPS) of -$0.11, up 57.14% year over year. Total CPIX earnings for the quarter were -$1.54 million. In the same quarter last year, Cumberland Pharmaceuticals's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Cumberland Pharmaceuticals stock.

Is Cumberland Pharmaceuticals profitable or losing money?

As of the last Cumberland Pharmaceuticals earnings report, Cumberland Pharmaceuticals is currently losing money. Cumberland Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$10.87 million, a 348.14% increase year over year.

What was CPIX's earnings growth in the past year?

As of Cumberland Pharmaceuticals's earnings date in Invalid Date, Cumberland Pharmaceuticals's earnings has grown year over year. CPIX earnings in the past year totalled -$10.87 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.